Course description
This course in Neuropsychopharmacology will take a deep dive into the neurobiological mechanisms, the translational value of different preclinical research models, and the current and emerging treatment strategies (e.g. fast-acting anti-depressants and psychedelics) for major psychiatric disorders, including affective disorders, schizophrenia, addiction and anxiety-related conditions. The lectures will cover the state-of-the art research in this field from experts across neuroscience, pharmacology, medical imaging and psychiatry.
The course is aimed for doctoral students with an interest in clinical/translational and preclinical research of psychiatric disorders.
Prerequisites and Selection
Prerequisite courses, or equivalent
No prerequisite courses, or equivalent, demanded for this course.
Selection
Selection will be based on:
1) the relevance of the course syllabus for the applicant’s individual study plan/research (according to written motivation).
2) start date of doctoral studies (priority given to earlier start date).
Course director
Kent Jardemark
Vasco Sousa
Course syllabus
K8F2526
Department
Department of Clinical Neuroscience
Doctoral programme
Neuroscience
Type of course
**Other course
Keywords
Neuropharmacology, Neuropsychopharmacology, psychiatric disorders, neuroscience, neurovetenskap, neurofarmacologi, psykiatriska sjukdomar, Psychiatric disorders, mood disorders, humörstörningar, antidepressives, antipsychotics, antidepressiva medel, antipsykotika